Cellis
PrivateLast Round
Grant
May 5, 2026
Total Funding Raised
$31.53M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Cellis is a biotechnology company that develops cell-based oncology therapies using a proprietary Macrophage Drug Conjugate (MDC) platform to target tumor microenvironments.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cellis Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Cellis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 5, 2026 | ||||
| Series B | Feb 1, 2026 | ||||
| Grant | Dec 17, 2024 | ||||
| Grant | Nov 28, 2024 | ||||
| Grant | Nov 1, 2022 |
Key People
Founding team and executive leadership
Cellis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| National Centre for Research and Development | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 5, 2026
Received grant funding from the Ministry of Funds and Regional Policy.
- Nov 1, 2022
Secured $2.47M from the European Innovation Council.
Cellis Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cellis's valuation, stock price, and market status.